The Internationalization of Chinese IVD Companies
In 2024, with the advancement of technology, the contraction of the domestic market due to centralized procurement of Chinese government, and the deepening of international cooperation, the outbound strategy of Chinese IVD (In Vitro Diagnostics) enterprises becomes particularly important.
Mindray Bio - Medical has established subsidiaries and offices in the United States, and set up research and development centers in Silicon Valley, Seattle, and New Jersey. It is gradually building an independent and comprehensive medical product innovation system spanning planning, research and development, and registration (OBM model)
Sansure Biotech has established overseas subsidiaries in Indonesia, France, the United Kingdom, the Philippines, and the United States, and has set up offices in key countries such as Thailand and Saudi Arabia. The company has signed national-level project cooperation agreements with multiple countries, among which several projects including POCT (Point of Care Testing), blood screening, tuberculosis, HPV (Human Papillomavirus), and others have entered the substantive implementation phase. Additionally, the project for localized production cooperation of molecular diagnostic products in Indonesia is also progressing in an orderly manner.
As of the end of the first half of 2023, Shenzhen New Industries Biomedical Engineering has established eight wholly-owned overseas subsidiaries and has set up global service centers in countries such as the United States, Romania, Spain, and Brazil, providing comprehensive overseas services throughout the process.
领英推荐
The strategic cooperation model between enterprises is an important approach in the "going global" strategy of Chinese IVD companies. It involves establishing collaborative relationships with international partners to jointly advance product development, regulatory approval, and commercialization.
Call for Roadshow presenters at IVD CHINA
If you are International Diagnostic company that are looking for partners of collaborations in Chinese market, please submit your business portfolio to the organizing committee of IVD CHINA – [email protected], after the internal review of the portfolio, the organizing committee will send you the approval email for the roadshow opportunities
The international IVD Roadshow session will be about 15 mins of presentation at IVD CHINA. The IVD China 2024 is an international exhibition and conference with a scale of 5000 attendees, 1000+ IVD and ICLs, and over 200+Speakers.